Organ | Experimental Groups (n = 8) | |||
---|---|---|---|---|
Control | Dp44mT (0.4 mg/kg/day i.v.) | DpC (5 mg/kg/day i.v.) | Gemcitabine (5 mg/kg/3 days i.p.) | |
Body weight loss, % of total weight | 104.9 ± 4.6 | 99.4 ± 5.7 | 88.0 ± 6.5*** | 104.5 ± 2.2 |
Liver, g | 0.96 ± 0.11 | 0.88 ± 0.03 | 0.80 ± 0.03 | 1.04 ± 0.03 |
Spleen, g | 0.12 ± 0.01 | 0.13 ± 0.01 | 0.08 ± 0.01** | 0.13 ± 0.01 |
Kidney, g | 0.15 ± 0.02 | 0.16 ± 0.02 | 0.17 ± 0.02 | 0.19 ± 0.03 |
Heart, g | 0.10 ± 0.01 | 0.10 ± 0.01 | 0.09 ± 0.01 | 0.10 ± 0.01 |
Brain, g | 0.32 ± 0.02 | 0.31 ± 0.01 | 0.30 ± 0.01 | 0.32 ± 0.01 |
Tumor, g | 0.29 ± 0.07 | 0.12 ± 0.03* | 0.04 ± 0.01*** | 0.07 ± 0.02** |
* p < 0.05.
** p < 0.01.
*** p < 0.001.